Araclon Biotech

Vía de la Hispanidad, 21
Zaragoza
50009

Tel: 34-976-796-562
Fax: 34-976-217-802

Show jobs for this employer

About Araclon Biotech

Araclon Biotech is a company dedicated to the research and development of therapies and diagnostic methods to be applied to degenerative diseases, currently focusing on Alzheimer’s disease. At present, Araclon is working on four different projects:
The first of these focuses on the diagnosis of Alzheimer’s disease (with a detection kit for beta-amyloid 40 and 42 proteins in blood already patented).
The second is centred on Alzheimer’s therapy (immunotherapy based).
The third is an emerging project, which attempts to respond to the challenge of predicting Alzheimer’s disease in totally asymptomatic individuals.
And finally, a project related to the development of a therapy for the Parkinson’s disease
YEAR FOUNDED:
2004
LEADERSHIP:
CEO: Manuel Saras
CLINICAL TRIAL
Please click here for clinical trial information.

8 articles about Araclon Biotech